000 01259 a2200361 4500
005 20250516041148.0
264 0 _c20111220
008 201112s 0 0 eng d
022 _a1744-7623
024 7 _a10.1517/14728214.2011.588600
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPantano, Francesco
245 0 0 _aNew targets, new drugs for metastatic bone pain: a new philosophy.
_h[electronic resource]
260 _bExpert opinion on emerging drugs
_cSep 2011
300 _a403-5 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_xpharmacology
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aBone Neoplasms
_xcomplications
650 0 4 _aDenosumab
650 0 4 _aHumans
650 0 4 _aPain
_xdrug therapy
650 0 4 _aRANK Ligand
_xpharmacology
700 1 _aZoccoli, Alice
700 1 _aIuliani, Michele
700 1 _aLanzetta, Gaetano
700 1 _aVincenzi, Bruno
700 1 _aTonini, Giuseppe
700 1 _aSantini, Daniele
773 0 _tExpert opinion on emerging drugs
_gvol. 16
_gno. 3
_gp. 403-5
856 4 0 _uhttps://doi.org/10.1517/14728214.2011.588600
_zAvailable from publisher's website
999 _c20883869
_d20883869